Gene · 4277
Papers3,381
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 3,381
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Comparing methods for constructing and representing human pangenome graphs. | Genome Biol | 2023 | 38037131 | PubTator, text mining | PubMed |
| Hypoxia mediates immune escape of pancreatic cancer cells by affecting miR-1275/AXIN2 in natural killer cells. | Front Immunol | 2023 | 38035113 | PubTator, text mining | PubMed |
| High population frequencies of MICA copy number variations originate from independent recombination events. | Front Immunol | 2023 | 38035108 | PubTator, text mining | PubMed |
| The impact of sMICA/sMICB on immunochemotherapy outcomes in newly diagnosed diffuse large B-cell lymphoma. | Front Oncol | 2023 | 38033491 | PubTator, text mining | PubMed |
| Charting a killer course to the solid tumor: strategies to recruit and activate NK cells in the tumor microenvironment. | Front Immunol | 2023 | 38022679 | PubTator, text mining | PubMed |
| Integrated analysis of single-cell RNA-seq and bulk RNA-seq reveals RNA N6-methyladenosine modification associated with prognosis and drug resistance in acute myeloid leukemia. | Front Immunol | 2023 | 38022588 | PubTator, text mining | PubMed |
| Ligand-based targeting of c-kit using engineered γδ T cells as a strategy for treating acute myeloid leukemia. | Front Immunol | 2023 | 38022523 | PubTator, text mining | PubMed |
| Development of a diagnostic and risk prediction model for Alzheimer's disease through integration of single-cell and bulk transcriptomic analysis of glutamine metabolism. | Front Aging Neurosci | 2023 | 38020758 | PubTator, text mining | PubMed |
| A web-based genome-wide association study reveals the susceptibility loci of common adverse events following COVID-19 vaccination in the Japanese population. | Sci Rep | 2023 | 38012279 | PubTator, text mining | PubMed |
| CAR-T-Cell Therapy in Multiple Myeloma: B-Cell Maturation Antigen (BCMA) and Beyond. | Vaccines (Basel) | 2023 | 38006053 | PubTator, text mining | PubMed |
| Key Genes of the Immune System and Predisposition to Acquired Hemophilia A: Evidence from a Spanish Cohort of 49 Patients Using Next-Generation Sequencing. | Int J Mol Sci | 2023 | 38003562 | PubTator, text mining | PubMed |
| Dysregulation of Non-Coding RNAs: Roles of miRNAs and lncRNAs in the Pathogenesis of Multiple Myeloma. | Noncoding RNA | 2023 | 37987364 | PubTator, text mining | PubMed |
| Chimeric Antigen Receptor T Cell Therapy in Acute Myeloid Leukemia: Trials and Tribulations. | Hematol Rep | 2023 | 37987319 | PubTator, text mining | PubMed |
| Coordinated immune dysregulation in Juvenile Dermatomyositis revealed by single-cell genomics. | bioRxiv | 2023 | 37986917 | PubTator, text mining | PubMed |
| Immunological and senescence biomarker profiles in patients after spontaneous clearance of hepatitis C virus: gender implications for long-term health risk. | Immun Ageing | 2023 | 37978401 | PubTator, text mining | PubMed |
| Estimation of parasitaemia in imported falciparum malaria using the results of a combined rapid diagnostic test. No big help from haematological parameters. | Malar J | 2023 | 37974257 | PubTator, text mining | PubMed |
| Establishment and verification of a prognostic risk score model based on immune genes for hepatocellular carcinoma in an Asian population. | Transl Cancer Res | 2023 | 37969383 | PubTator, text mining | PubMed |
| Semi-mechanistic population pharmacokinetic/pharmacodynamic modeling of a Plasmodium elongation factor 2 inhibitor cabamiquine for prevention and cure of malaria. | Antimicrob Agents Chemother | 2023 | 37966273 | PubTator, text mining | PubMed |
| Pan-cancer analysis and in vitro validation of the oncogenic and prognostic roles of AURKA in human cancers. | Front Oncol | 2023 | 37965456 | PubTator, text mining | PubMed |
| miRNAs: Targets to Investigate Herpesvirus Infection Associated with Neurological Disorders. | Int J Mol Sci | 2023 | 37958855 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4277/papers?page=12